NDP leader Jagmeet Singh meets with Prime Minister Justin Trudeau on Parliament Hill in Ottawa on Thursday, Nov. 14, 2019.
The federal Liberal government and the NDP have come to an agreement on pharmacare, clearing the way for the two parties to continue operating under the confidence-and-supply agreement that has helped keep the government in power over the last two years.
Under the terms of the confidence-and-supply agreement signed in March 2022, the Liberal government committed to passing legislation — a Canada Pharmacare Act — by the end of 2023, in exchange for NDP support on key votes in the House of Commons. In December, the parties agreed to push back the deadline to March.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NDP and Liberals Reach Deal on National Pharmacare ProgramThe NDP has reached an agreement with the Liberals to introduce the first part of a national pharmacare program, covering birth control and diabetes medication. The legislation, to be tabled next week, provides funding for contraceptives and diabetes medications, but does not create a full national pharmacare program.
Read more »
The Liberals and NDP still have reasons to work together — are they good enough?NDP leader Jagmeet Singh meets with Prime Minister Justin Trudeau on Parliament Hill in Ottawa on Thursday, Nov. 14, 2019.
Read more »
NDP threatens stalling tactics, end of agreement with Liberals over slow pace of pharmacare talksNDP leader Jagmeet Singh meets with Prime Minister Justin Trudeau on Parliament Hill in Ottawa on Thursday, Nov. 14, 2019.
Read more »
NDP says pharmacare talks with Liberals are now focused on who pays for whatNDP leader Jagmeet Singh speaks at a health-care rally on Parliament Hill in Ottawa on Tuesday, Feb. 13, 2024.
Read more »
NDP optimistic pharmacare deal with Liberals can be reached by deadlineHealth critic Don Davies says negotiations that would lead to a system where users ‘pay less’ for pharmaceuticals are in the late stages
Read more »
Conservative motion, backed by NDP, produced $40M in regulatory relief for BellConservative Leader Pierre Poilievre is rejecting the idea that his party played a role in granting $40 million in regulatory relief to Bell Media.
Read more »